White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations-Reference-Cited by-同舟云学术

White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations

Published:2013-02-15 Issue:6 Volume:28 Page:772-778
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Agosta Federica¹,Kostic Vladimir S.²,Davidovic Kristina¹²,Kresojević Nikola²,Sarro Lidia¹³,Svetel Marina²,Stanković Iva²,Comi Giancarlo³,Klein Christine⁴,Filippi Massimo¹³

Affiliation:

1. Neuroimaging Research Unit; San Raffaele Scientific Institute; Vita-Salute San Raffaele University; Milan Italy

2. Clinic of Neurology; Faculty of Medicine, University of Belgrade; Belgrade Serbia

3. Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience; San Raffaele Scientific Institute, Vita-Salute San Raffaele University; Milan Italy

4. Section of Clinical and Molecular Neurogenetics, Department of Neurology; University of Lubeck; Luebeck Germany

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference31 articles.

1. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease;Sidransky;N Engl J Med.,2009

2. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease;Neumann;Brain.,2009

3. Association of glucocerebrosidase mutations with dementia with Lewy bodies;Clark;Arch Neurol.,2009

4. Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders;Goker-Alpan;Acta Neuropathol.,2010

5. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases;Hughes;J Neurol Neurosurg Psychiatry.,1992

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice;Molecular Neurodegeneration;2024-03-07

2. Neural plasticity in Parkinson’s disease: a neuroimaging perspective;Neural Regeneration Research;2023-10-02

3. Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative;Journal of Parkinson's Disease;2023-09-08

4. Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease;Neurobiology of Disease;2023-09

5. Fiber‐Specific White Matter Alterations in Parkinson's Disease Patients with GBA Gene Mutations;Movement Disorders;2023-08-22